CALIX, INC·4

Nov 12, 4:04 PM ET

Eleniak Shane Todd Marshall 4

4 · CALIX, INC · Filed Nov 12, 2025

Insider Transaction Report

Form 4
Period: 2025-11-10
Eleniak Shane Todd Marshall
Chief Product Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-10$8.03/sh+24,000$192,72024,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-1024,00024,000 total
    Exercise: $8.03Exp: 2029-02-14Common Stock (24,000 underlying)
  • Sale

    Common Stock

    2025-11-10$64.14/sh24,000$1,539,2400 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.295, inclusive. Full information on the number of shares sold at each sale price is available upon request.
  • [F2]100% of the shares subject to the option were fully vested and exercisable on February 14, 2023.

Documents

1 file
  • 4
    wk-form4_1762981474.xmlPrimary

    FORM 4